施樂輝 SNN 深滬

已收盤 02-06 16:00:00 美东时间

34.69

-0.480

-1.36%

華盛通

立即下載

最高34.715
今開34.21
成交量 73.48万股
最低 34.20
昨收 35.17
總市值 147.24亿
52周最高 38.505
市盈率 ^靜 36.87
換手率 0.17%
52周最低 23.625
委比 36.56%
總股本 4.24亿
歷史最高 47.883
量比 0.75
振幅 1.46%
歷史最低 8.893
每手 1
風險率 3.82%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

Smith+Nephew Sets 2 March 2026 Date for 2025 Full-Year Results

Smith & Nephew Snats ( ($SNN) ) has provided an update. Smith+Nephew announ...

02-06 01:48
Smith & Nephew Executives Buy ADS under Employee Stock Purchase Plan

Smith & Nephew Snats ( ($SNN) ) has issued an announcement. On 16 January 2...

01-23 22:47
Smith+Nephew Closes US$450m Integrity Orthopaedics Deal to Bolster Sports Medicine Portfolio

Smith & Nephew Snats ( ($SNN) ) has issued an update. On 21 January 2026, S...

01-22 01:19
Smith+Nephew completes acquisition of Integrity Orthopaedics; establishes unrivalled portfolio for shoulder repair

<p>Smith+Nephew has acquired Integrity Orthopaedics to enhance its sports medicine shoulder repair business, particularly in rotator cuff repair (RCR). Integrity Orthopaedics developed the innovative Tendon Seam system, designed to significantly reduce re-tear rates and improve patient outcomes. The system features patented microanchors, continuous suture, and a simplified surgical technique, receiving FDA clearance in 2023. With over 500,000 RCR...

01-21 17:15
Jim Cramer Says Sell Super Micro — Calls A European Chipmaker 'Cheap And Good'

Jim Cramer recommended selling Super Micro Computer Inc. and doesn't recommend Alkermes plc. Huntington Bancshares is 'terrific.' Smith & Nephew plc should be sold. Cramer also recommends buying Medline Inc. and STMicroelectronics N.V.

01-20 22:02
Smith+Nephew to Acquire Integrity Orthopaedics to Bolster Shoulder Repair Portfolio

Smith & Nephew Snats ( ($SNN) ) has issued an announcement. On 12 January 2...

01-13 01:48
Smith+Nephew Unveils RISE Strategy and 2028 Financial Targets

Smith & Nephew Snats ( ($SNN) ) just unveiled an update. On December 8, 202...

2025-12-08 20:17
Smith & Nephew Announces Vesting of CEO’s Restricted Shares

The latest announcement is out from Smith & Nephew Snats ( ($SNN) ). On Nov...

2025-11-13 01:27
美股大行评级 | CoreWeave、Monday遭美银、小摩等多家大行下调目标价；中金首予Nebius "跑赢大市"评级，目标价143美元

今日重点评级关注：Piper Sandler：维持MeiraGTx Hldgs"超配"评级，目标价从28美元升至30美元；RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从26美元升至32美元

2025-11-12 11:43
Smith & Nephew Executives Participate in Share Purchase Plan Post-Dividend

Smith & Nephew Snats ( ($SNN) ) has shared an update. On November 7, 2025, ...

2025-11-10 22:57

派息除權日	每股總股息	派息日期
2025-10-03	0.28	2025-11-07
2025-03-28	0.45	2025-05-28
2024-10-04	0.27	2024-11-08
2024-04-01	0.45	2024-05-22
2023-10-05	0.28	2023-11-01
2023-03-30	0.45	2023-05-17
2022-09-29	0.28	2022-10-26
2022-03-31	0.45	2022-05-11
2021-09-30	0.28	2021-10-27
2021-04-05	0.45	2021-05-12
2020-10-01	0.28	2020-10-28
2020-04-02	0.45	2020-05-06
2019-10-03	0.28	2019-10-30
2019-04-04	0.43	2019-05-08
2018-10-04	0.27	2018-10-31
2018-04-05	0.44	2018-05-09
2017-10-05	0.24	2017-11-01
2017-03-29	0.37	2017-05-10
2016-10-05	0.24	2016-10-25
2016-04-20	0.37	2016-05-11
2015-10-07	0.23	2015-10-27
2015-04-15	0.36	2015-05-06
2014-10-22	0.21	2014-11-11
2014-04-17	0.83	2014-05-07
2013-10-09	0.51	2013-10-29
2013-04-17	0.79	2013-05-08
2012-10-10	0.49	2012-10-30
2012-04-18	0.52	2012-05-09
2011-10-12	0.32	2011-11-01
2011-04-29	0.47	2011-05-19
2010-10-13	0.29	2010-11-02
2010-04-21	0.43	2010-05-12
2009-10-14	0.27	2009-11-03
2009-04-15	0.41	2009-05-08
2008-10-15	0.25	2008-11-07
2008-04-16	0.37	2008-05-09
2007-10-17	0.23	2007-11-09
2007-04-18	0.34	2007-05-21
2006-10-18	0.20	2006-11-10
2006-04-19	0.31	2006-05-12
2005-10-19	0.18	2005-11-21
2005-04-20	0.30	2005-05-23
2004-10-20	0.17	2004-11-22
2004-04-21	0.27	2004-05-24
2003-08-13	0.29	2003-09-22
2003-04-17	0.49	2003-05-27
2002-10-16	0.28	2002-11-25
2002-04-17	0.42	2002-05-28
2001-11-07	0.25	2001-12-17
2001-04-18	0.40	2001-05-29
2000-11-08	0.24	2000-12-18
2000-08-07	5.56	2000-08-04
2000-05-04	0.60	2000-06-12

公司名稱	施乐辉
行業分類	医疗设备
業務描述	Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

施樂輝 SNN 深 滬

34.69

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

施樂輝 SNN 深滬